US 9452186
Enhanced stem cell composition
granted A61KA61K2035/124A61K35/28
Quick answer
US patent 9452186 (Enhanced stem cell composition) held by Fate Therapeutics, Inc. expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K2035/124, A61K35/28, A61K35/51, A61P